The long-suffering saga has been kept alive this decade by TV alone – but even that will perish if the new movie fails to extend its universe Star Wars has always been big on prophecy. Yoda peers into the future like Nostradamus with messed-up syntax, the Emperor cackles that everything is proceeding exactly as he has foreseen, Darth Vader breathes doom through the front grille of his shiny death ...
The long-suffering saga has been kept alive this decade by TV alone – but even that will perish if the new movie fails to extend its universe Star Wars has always been big on prophecy. Yoda peers into the future like Nostradamus with messed-up syntax, the Emperor cackles that everything is proceeding exactly as he has foreseen, Darth Vader breathes doom through the front grille of his shiny death helmet. And yet not even the most omniscient of Jedi could have predicted that the franchise responsible for practically inventing the modern Hollywood blockbuster would end up as a TV-centric operation with only occasional forays on to the big screen. Which is why it comes as a genuine shock to realise that, ahead of the release of new movie The Mandalorian and Grogu later this month, it has been more than six years since Star Wars last hit the multiplex. Then again, perhaps the real humdinger is that it hasn’t been longer. The most recent Disney Star Wars film, JJ Abrams’ The Rise of Skywalker , did not so much conclude the long-running space saga as destroy several decades of perfectly serviceable mythology and ruin all sense of congruence with previous films. It was frantic, weirdly apologetic (about previous instalment The Last Jedi ) and overstuffed with dodgy fan service. It was essentially a $590m act of narrative panic. Continue reading...
Profusa ( PFSA ) on Friday said that a Nasdaq Hearings Panel approved the transfer of the company’s securities listing from the Nasdaq Global Market to the Nasdaq Capital Market. The digital health company said continued listing on Nasdaq remains subject to meeting certain interim milestones and complying with bid price and stockholders’ equity requirements for the Capital Market tier by July 6, 2...
Profusa ( PFSA ) on Friday said that a Nasdaq Hearings Panel approved the transfer of the company’s securities listing from the Nasdaq Global Market to the Nasdaq Capital Market. The digital health company said continued listing on Nasdaq remains subject to meeting certain interim milestones and complying with bid price and stockholders’ equity requirements for the Capital Market tier by July 6, 2026. The company disclosed the determination in a letter dated May 6, 2026. Source: Press Release More on Profusa, Inc. Financial information for Profusa, Inc.
Devon Energy should continue to rally even if the oil rally fizzles as bullish catalysts line up for the stock — including the closing of its merger with Coterra — according to Jefferies. The investment firm upgraded the oil and gas producer to buy from hold. It also raised its price target on shares to $62 from $53, implying 37% upside from Thursday's close. Devon is "too cheap to ignore with cat...
Devon Energy should continue to rally even if the oil rally fizzles as bullish catalysts line up for the stock — including the closing of its merger with Coterra — according to Jefferies. The investment firm upgraded the oil and gas producer to buy from hold. It also raised its price target on shares to $62 from $53, implying 37% upside from Thursday's close. Devon is "too cheap to ignore with catalysts," analyst Lloyd Byrne said Thursday in a note to clients. "Pullbacks in the front of the oil curve create opportunity, and DVN has multiple catalysts for absolute and relative outperformance post-[merger] close." Indeed, Devon trades at a forward price-to-earnings ratio of 8.28, according to FactSet. That's well below the S & P 500's multiple of more than 21. Oil prices have recently pulled back amid a tenuous ceasefire between the U.S. and Iran . U.S. West Texas Intermediate futures were last trading at $94.94, or nearly 7% lower for the week. Futures contracts expiring later in the year also point to lower prices. However, the stock — up 24% year to date — will get a boost after it completed its merger with Coterra Energy, which closed this week. The deal should produce roughly $1 billion in synergies, likely boosting Devon stock, according to Jefferies. DVN YTD mountain Shares are up 24% in the year to date. The company also seems likely to divest from non-core assets such as Marcellus Shale, which could "eliminate debt and boost returns," according to the analyst. Jefferies' call falls in line with consensus on the Street. Of the 28 analysts covering Devon, 24 have a buy or strong buy on the stock, LSEG data shows.
TomasSereda/iStock via Getty Images The largest contractor at Barrick Mining's ( B ) Loulo-Gounkoto gold complex in Mali is shutting operations in the country and laying off more than 600 workers, Reuters reported Thursday. Barrick ( B ) reportedly does not plan to renew its deal with contractor Gounkoto Mining Services in 2026, and it is unclear whether it would for 2027. The move follows slu...
TomasSereda/iStock via Getty Images The largest contractor at Barrick Mining's ( B ) Loulo-Gounkoto gold complex in Mali is shutting operations in the country and laying off more than 600 workers, Reuters reported Thursday. Barrick ( B ) reportedly does not plan to renew its deal with contractor Gounkoto Mining Services in 2026, and it is unclear whether it would for 2027. The move follows sluggish production and investment at the complex, according to the report , after Barrick ( B ) regained control from Malian administrators following a standoff with the government over taxes and ownership. The departure of Gounkoto Mining Services, which managed extraction at the Gounkoto open-pit mine and the Yalea North mine, is said to be unconnected to the security threats Mali is facing from insurgent groups, whose recent attacks occurred far from the mining complex. Loulo-Gounkoto, one of Africa's biggest gold mines, produced 80K oz of gold in Q1 2026 and is projected to produce 103K oz in Q2, well below average output before the standoff but still an increase from levels under the provisional administration, Reuters said. More on Barrick Mining Barrick's North America IPO Is The Catalyst I Was Waiting For Barrick Mining: IPO Spinoff Dream Hits Royalty Shocker And Margin Squeeze Barrick: You Haven't Seen Anything Yet
(RTTNews) - A closely watched report released by the Labor Department on Friday showed employment in the U.S. increased by much more than expected in the month of April.
(RTTNews) - A closely watched report released by the Labor Department on Friday showed employment in the U.S. increased by much more than expected in the month of April.
mixmotive/iStock Editorial via Getty Images S&P Global ( SPGI ) announced on Friday the formation of a board of directors for the unit to be spun off into a separate company by mid-2026, Mobility Global. Joseph Hinrichs, former CEO of CSX ( CSX ), is set to lead the eight-person board as its chairman. Bill Eager, president of S&P Global Mobility and CEO-designate of Mobility Global, will also join...
mixmotive/iStock Editorial via Getty Images S&P Global ( SPGI ) announced on Friday the formation of a board of directors for the unit to be spun off into a separate company by mid-2026, Mobility Global. Joseph Hinrichs, former CEO of CSX ( CSX ), is set to lead the eight-person board as its chairman. Bill Eager, president of S&P Global Mobility and CEO-designate of Mobility Global, will also join the board. The other members to be included in the board are Eric Aboaf, CFO of S&P Global; Heather Lavallee, CEO of Voya Financial ( VOYA ); Monique Leroux, former CEO of Desjardins Group; Mark Peek, former CFO of Workday ( WDAY ); Shilpa Ranganathan, chief product officer of Expedia Group ( EXPE ); and Alexander Taussig, board partner at Lightspeed Venture Partners. More on S&P Global S&P Global Inc. (SPGI) Presents at Barclays 18th Annual Americas Select Conference Transcript SPGI: The February Bears Were Wrong (Earnings Review) S&P Global Inc. (SPGI) Q1 2026 Earnings Call Transcript S&P Global mulls changing IPO rules for megacap companies S&P Ratings, Moody's, and Fitch questioned about ESG policies by 23 states
CG Oncology press release ( CGON ): Q1 GAAP EPS of -$0.71. Revenue of $1.08B. Cash Position: Cash, cash equivalents and marketable securities as of March 31, 2026 were $1.1 billion, compared with $742.2 million as of December 31, 2025. The March 31, 2026, cash includes net proceeds of approximately $391.4 million from a total of 6,941,407 shares sold through the Company’s at-the-market (ATM) facil...
CG Oncology press release ( CGON ): Q1 GAAP EPS of -$0.71. Revenue of $1.08B. Cash Position: Cash, cash equivalents and marketable securities as of March 31, 2026 were $1.1 billion, compared with $742.2 million as of December 31, 2025. The March 31, 2026, cash includes net proceeds of approximately $391.4 million from a total of 6,941,407 shares sold through the Company’s at-the-market (ATM) facility in Q1 based on reverse inquiries from existing and new, high-quality funds. More on CG Oncology CG Oncology: Passing A Red Line For What I Would Call A Reasonable Valuation (Rating Downgrade) Seeking Alpha’s Quant Rating on CG Oncology Historical earnings data for CG Oncology Financial information for CG Oncology
CG Oncology press release ( CGON ): Q1 GAAP EPS of -$0.71. Revenue of $1.08M. Cash Position: Cash, cash equivalents and marketable securities as of March 31, 2026 were $1.1 billion, compared with $742.2 million as of December 31, 2025. The March 31, 2026, cash includes net proceeds of approximately $391.4 million from a total of 6,941,407 shares sold through the Company’s at-the-market (ATM) facil...
CG Oncology press release ( CGON ): Q1 GAAP EPS of -$0.71. Revenue of $1.08M. Cash Position: Cash, cash equivalents and marketable securities as of March 31, 2026 were $1.1 billion, compared with $742.2 million as of December 31, 2025. The March 31, 2026, cash includes net proceeds of approximately $391.4 million from a total of 6,941,407 shares sold through the Company’s at-the-market (ATM) facility in Q1 based on reverse inquiries from existing and new, high-quality funds. More on CG Oncology CG Oncology: Passing A Red Line For What I Would Call A Reasonable Valuation (Rating Downgrade) Seeking Alpha’s Quant Rating on CG Oncology Historical earnings data for CG Oncology Financial information for CG Oncology
Unemployment remained steady at 4.3% as the US-Israel war on Iran continues to rattle the American economy US employers added 115,000 jobs in April and the unemployment rate remained steady at 4.3% as the US-Israel war with Iran continued to drive up economic uncertainty. Economists projected about 55,000 new jobs and a 4.3% unemployment rate. A day earlier, the labor department announced 200,000 ...
Unemployment remained steady at 4.3% as the US-Israel war on Iran continues to rattle the American economy US employers added 115,000 jobs in April and the unemployment rate remained steady at 4.3% as the US-Israel war with Iran continued to drive up economic uncertainty. Economists projected about 55,000 new jobs and a 4.3% unemployment rate. A day earlier, the labor department announced 200,000 people filed for weekly unemployment benefits, a slight increase from the week before. Continue reading...